Analysts at StockNews.com assumed coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report)...
DUBLIN--(BUSINESS WIRE)--The "Advanced Therapy Medicinal Products - Global Strategic Business Report...
Merger Arbitrage BLUE: Carlyle (CG) and SK Capital announced that Beacon Merger Sub has extended the...
Despite making an unsolicited bid for gene therapy maker bluebird bio, Ayrmid failed to deliver a bi...
A rival bid by Ayrmid for bluebird bio hasn't crossed the finish line, the biotech said, after faili...